Neilesh Shailesh Ghodadra - Oct 7, 2025 Form 3 Insider Report for Turn Therapeutics Inc. (TTRX)

Role
Chief Medical Officer, Director
Signature
/s/ Zuraiz Chaudhary, attorney-in-fact for Neil Ghodadra
Stock symbol
TTRX
Transactions as of
Oct 7, 2025
Transactions value $
$0
Form type
3
Date filed
10/7/2025, 07:11 PM
Next filing
Oct 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ghodadra Neilesh Shailesh Chief Medical Officer, Director C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE /s/ Zuraiz Chaudhary, attorney-in-fact for Neil Ghodadra 2025-10-07 0002089048

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TTRX Stock Option (right to buy) Oct 7, 2025 Common Stock 1M $1.25 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option became exercisable as to 1/4 of the shares of common stock underlying the stock option on October 12, 2018, 1/4 of the shares on January 1, 2019, and 1/8 of the shares on the first day of each subsequent quarter thereafter.
F2 The number of shares of common stock underlying the stock option and the applicable exercise price give effect to the 2-for-1 forward stock split, that took effect on September 30, 2025.

Remarks:

Exhibit 24 - Power of Attorney